Kestra Medical Technologies (KMTS) Competitors

Kestra Medical Technologies logo
$26.63 -1.66 (-5.87%)
Closing price 04:00 PM Eastern
Extended Trading
$26.65 +0.02 (+0.08%)
As of 04:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

KMTS vs. TFX, HAE, MMED, LIVN, and ITGR

Should you buy Kestra Medical Technologies stock or one of its competitors? Kestra Medical Technologies's main competitors and comparable companies include Teleflex (TFX), Haemonetics (HAE), MiniMed Group (MMED), LivaNova (LIVN), and Integer (ITGR). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Kestra Medical Technologies compare to Teleflex?

Kestra Medical Technologies (NASDAQ:KMTS) and Teleflex (NYSE:TFX) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, earnings, dividends, profitability, institutional ownership, risk and valuation.

Kestra Medical Technologies has higher earnings, but lower revenue than Teleflex. Kestra Medical Technologies is trading at a lower price-to-earnings ratio than Teleflex, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kestra Medical Technologies$95.13M17.71-$131.61M-$2.67N/A
Teleflex$1.99B3.31-$905.64M$8.2320.18

95.6% of Teleflex shares are held by institutional investors. 5.3% of Kestra Medical Technologies shares are held by company insiders. Comparatively, 0.7% of Teleflex shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Teleflex has a net margin of 13.51% compared to Kestra Medical Technologies' net margin of -140.43%. Teleflex's return on equity of 10.57% beat Kestra Medical Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Kestra Medical Technologies-140.43% -63.83% -44.76%
Teleflex 13.51%10.57%4.96%

Kestra Medical Technologies presently has a consensus price target of $29.00, indicating a potential upside of 2.51%. Teleflex has a consensus price target of $163.30, indicating a potential downside of 1.68%. Given Kestra Medical Technologies' higher possible upside, analysts plainly believe Kestra Medical Technologies is more favorable than Teleflex.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Kestra Medical Technologies
1 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.50
Teleflex
0 Sell rating(s)
6 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.58

Kestra Medical Technologies has a beta of 0.45, indicating that its stock price is 55% less volatile than the broader market. Comparatively, Teleflex has a beta of 0.85, indicating that its stock price is 15% less volatile than the broader market.

In the previous week, Kestra Medical Technologies and Kestra Medical Technologies both had 5 articles in the media. Kestra Medical Technologies' average media sentiment score of 0.87 beat Teleflex's score of 0.07 indicating that Kestra Medical Technologies is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Kestra Medical Technologies
3 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Teleflex
0 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Teleflex beats Kestra Medical Technologies on 9 of the 14 factors compared between the two stocks.

How does Kestra Medical Technologies compare to Haemonetics?

Kestra Medical Technologies (NASDAQ:KMTS) and Haemonetics (NYSE:HAE) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, media sentiment, risk, valuation and profitability.

Kestra Medical Technologies currently has a consensus target price of $29.00, suggesting a potential upside of 2.51%. Haemonetics has a consensus target price of $130.50, suggesting a potential upside of 6.29%. Given Haemonetics' stronger consensus rating and higher probable upside, analysts plainly believe Haemonetics is more favorable than Kestra Medical Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Kestra Medical Technologies
1 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.50
Haemonetics
0 Sell rating(s)
3 Hold rating(s)
9 Buy rating(s)
1 Strong Buy rating(s)
2.85

Haemonetics has higher revenue and earnings than Kestra Medical Technologies. Kestra Medical Technologies is trading at a lower price-to-earnings ratio than Haemonetics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kestra Medical Technologies$95.13M17.71-$131.61M-$2.67N/A
Haemonetics$1.33B4.19$97.31M$2.2355.06

In the previous week, Haemonetics had 5 more articles in the media than Kestra Medical Technologies. MarketBeat recorded 10 mentions for Haemonetics and 5 mentions for Kestra Medical Technologies. Kestra Medical Technologies' average media sentiment score of 0.87 beat Haemonetics' score of 0.40 indicating that Kestra Medical Technologies is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Kestra Medical Technologies
3 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Haemonetics
2 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

99.7% of Haemonetics shares are owned by institutional investors. 5.3% of Kestra Medical Technologies shares are owned by company insiders. Comparatively, 2.1% of Haemonetics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Haemonetics has a net margin of 7.52% compared to Kestra Medical Technologies' net margin of -140.43%. Haemonetics' return on equity of 27.42% beat Kestra Medical Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Kestra Medical Technologies-140.43% -63.83% -44.76%
Haemonetics 7.52%27.42%9.77%

Kestra Medical Technologies has a beta of 0.45, suggesting that its share price is 55% less volatile than the broader market. Comparatively, Haemonetics has a beta of 0.63, suggesting that its share price is 37% less volatile than the broader market.

Summary

Haemonetics beats Kestra Medical Technologies on 13 of the 16 factors compared between the two stocks.

How does Kestra Medical Technologies compare to MiniMed Group?

MiniMed Group (NASDAQ:MMED) and Kestra Medical Technologies (NASDAQ:KMTS) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, risk, earnings, institutional ownership, media sentiment, profitability, valuation and analyst recommendations.

MiniMed Group has a net margin of 0.00% compared to Kestra Medical Technologies' net margin of -140.43%. MiniMed Group's return on equity of 0.00% beat Kestra Medical Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
MiniMed GroupN/A N/A N/A
Kestra Medical Technologies -140.43%-63.83%-44.76%

MiniMed Group currently has a consensus price target of $24.13, suggesting a potential upside of 42.00%. Kestra Medical Technologies has a consensus price target of $29.00, suggesting a potential upside of 2.51%. Given MiniMed Group's stronger consensus rating and higher possible upside, analysts clearly believe MiniMed Group is more favorable than Kestra Medical Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
MiniMed Group
1 Sell rating(s)
4 Hold rating(s)
14 Buy rating(s)
0 Strong Buy rating(s)
2.68
Kestra Medical Technologies
1 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.50

Kestra Medical Technologies has lower revenue, but higher earnings than MiniMed Group. MiniMed Group is trading at a lower price-to-earnings ratio than Kestra Medical Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MiniMed Group$3.22B1.48-$333M-$0.68N/A
Kestra Medical Technologies$95.13M17.71-$131.61M-$2.67N/A

In the previous week, MiniMed Group had 3 more articles in the media than Kestra Medical Technologies. MarketBeat recorded 8 mentions for MiniMed Group and 5 mentions for Kestra Medical Technologies. Kestra Medical Technologies' average media sentiment score of 0.87 beat MiniMed Group's score of 0.45 indicating that Kestra Medical Technologies is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
MiniMed Group
1 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Kestra Medical Technologies
3 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

MiniMed Group beats Kestra Medical Technologies on 9 of the 12 factors compared between the two stocks.

How does Kestra Medical Technologies compare to LivaNova?

Kestra Medical Technologies (NASDAQ:KMTS) and LivaNova (NASDAQ:LIVN) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, risk, media sentiment, earnings, dividends, analyst recommendations, institutional ownership and valuation.

Kestra Medical Technologies has a beta of 0.45, meaning that its share price is 55% less volatile than the broader market. Comparatively, LivaNova has a beta of 0.91, meaning that its share price is 9% less volatile than the broader market.

LivaNova has a net margin of 13.01% compared to Kestra Medical Technologies' net margin of -140.43%. LivaNova's return on equity of 16.10% beat Kestra Medical Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Kestra Medical Technologies-140.43% -63.83% -44.76%
LivaNova 13.01%16.10%7.85%

Kestra Medical Technologies currently has a consensus target price of $29.00, indicating a potential upside of 2.51%. LivaNova has a consensus target price of $101.22, indicating a potential upside of 7.07%. Given LivaNova's stronger consensus rating and higher probable upside, analysts clearly believe LivaNova is more favorable than Kestra Medical Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Kestra Medical Technologies
1 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.50
LivaNova
0 Sell rating(s)
3 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.75

Kestra Medical Technologies has higher earnings, but lower revenue than LivaNova. Kestra Medical Technologies is trading at a lower price-to-earnings ratio than LivaNova, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kestra Medical Technologies$95.13M17.71-$131.61M-$2.67N/A
LivaNova$1.39B3.75-$242.47M$3.0031.51

In the previous week, Kestra Medical Technologies and Kestra Medical Technologies both had 5 articles in the media. Kestra Medical Technologies' average media sentiment score of 0.87 beat LivaNova's score of 0.15 indicating that Kestra Medical Technologies is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Kestra Medical Technologies
3 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
LivaNova
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

97.6% of LivaNova shares are held by institutional investors. 5.3% of Kestra Medical Technologies shares are held by insiders. Comparatively, 0.4% of LivaNova shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

LivaNova beats Kestra Medical Technologies on 10 of the 14 factors compared between the two stocks.

How does Kestra Medical Technologies compare to Integer?

Integer (NYSE:ITGR) and Kestra Medical Technologies (NASDAQ:KMTS) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, institutional ownership, dividends, profitability, valuation, media sentiment and analyst recommendations.

Integer has a net margin of 5.68% compared to Kestra Medical Technologies' net margin of -140.43%. Integer's return on equity of 11.84% beat Kestra Medical Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Integer5.68% 11.84% 5.98%
Kestra Medical Technologies -140.43%-63.83%-44.76%

Integer has higher revenue and earnings than Kestra Medical Technologies. Kestra Medical Technologies is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Integer$1.85B2.33$102.81M$2.9842.61
Kestra Medical Technologies$95.13M17.71-$131.61M-$2.67N/A

99.3% of Integer shares are owned by institutional investors. 1.1% of Integer shares are owned by insiders. Comparatively, 5.3% of Kestra Medical Technologies shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, Integer had 8 more articles in the media than Kestra Medical Technologies. MarketBeat recorded 13 mentions for Integer and 5 mentions for Kestra Medical Technologies. Integer's average media sentiment score of 0.93 beat Kestra Medical Technologies' score of 0.87 indicating that Integer is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Integer
6 Very Positive mention(s)
1 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Kestra Medical Technologies
3 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Integer has a beta of 0.6, indicating that its stock price is 40% less volatile than the broader market. Comparatively, Kestra Medical Technologies has a beta of 0.45, indicating that its stock price is 55% less volatile than the broader market.

Integer presently has a consensus target price of $113.67, suggesting a potential downside of 10.49%. Kestra Medical Technologies has a consensus target price of $29.00, suggesting a potential upside of 2.51%. Given Kestra Medical Technologies' stronger consensus rating and higher possible upside, analysts plainly believe Kestra Medical Technologies is more favorable than Integer.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Integer
0 Sell rating(s)
11 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.08
Kestra Medical Technologies
1 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.50

Summary

Integer beats Kestra Medical Technologies on 10 of the 15 factors compared between the two stocks.

Get Kestra Medical Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for KMTS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding KMTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

KMTS vs. The Competition

MetricKestra Medical TechnologiesHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$1.59B$5.85B$7.47B$11.44B
Dividend YieldN/A1.68%2.47%4.64%
P/E Ratio-9.9738.4832.8129.51
Price / Sales14.864.728.005.28
Price / CashN/A23.3720.8521.62
Price / Book5.984.124.383.65
Net Income-$131.61M$143.14M$3.51B$394.00M
7 Day Performance-6.95%-5.25%-6.16%-6.39%
1 Month Performance-9.33%-5.76%-7.05%-8.77%
1 Year Performance3.10%-1.61%-2.51%-8.48%

Kestra Medical Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
KMTS
Kestra Medical Technologies
1.6134 of 5 stars
$26.63
-5.9%
$29.00
+8.9%
+10.3%$1.59B$106.73MN/A443
TFX
Teleflex
2.7492 of 5 stars
$155.00
+1.2%
$163.30
+5.4%
+54.4%$6.07B$1.99B18.8315,500
HAE
Haemonetics
2.2003 of 5 stars
$123.16
+0.4%
$129.00
+4.7%
+65.0%$5.59B$1.33B55.233,009
MMED
MiniMed Group
3.1488 of 5 stars
$17.99
+0.6%
$24.13
+34.1%
N/A$5.03B$3.10BN/A2,800
LIVN
LivaNova
2.3198 of 5 stars
$91.32
+1.2%
$101.22
+10.8%
+75.4%$4.97B$1.39B30.443,300

Related Companies and Tools


This page (NASDAQ:KMTS) was last updated on 11/19/2026 by MarketBeat.com Staff.
From Our Partners